Conference abstract · 10 Aug 2017
Conference abstractPublished 29 Mar 2016
A practical example of model-based biomarker discovery by quantitative proteomics
University of Southern California, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The first documented case of cancer dates back to the Egyptians in 1600 BCE. A number of seminal discoveries since the ancient Egyptians have redefined our understanding of cancer. In fact, over the past several years, Cancer researchers have begun to reclassify tumors based on the molecular signalling pathways that cause malignant transformation. As a result, medical oncologists can prescribe drugs that specifically target the aberrant signalling pathway irrespective of the location of the Tumor. Modern cancer therapeutics is becoming targeted rather than systemic. This has brought upon a significant paradigm shift in medical treatment decisions and spurred the precision medicine era. Cancer cells must maintain a malleable phenotype in order to adapt to the selective pressures of the microenvironment and therapeutics. The cellsâÂ?Â? ability to modulate its proteome in the context of these selective pressures is an essential component of Tumor progression. Yet, to date, there has not been a systematic evaluation of the proteomic landscape associated with cancer progression, response to therapy and or resistance. We have demonstrated that the proteome of cancer cells which are sensitive to EGFR targeted drugs are quantitatively different from resistant cells. The shift from a sensitive to resistant phenotype was accompanied by a dramatic shift in the proteome. This finding suggests that cancer cells are able to rapidly alter their proteome signature in order to adapt to a selective pressures. Since the signature of resistant cells is different than the parental precursors, the possibility of discovering unique biomarkers of resistance is a reality.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Oct 2016
Quantitative proteomic analysis of prostate cancer for biomarker discovery and drug target identification
Research article · 2009
Discovery of Infectious Disease Biomarkers in Murine Anthrax Model Using Mass Spectrometry of the Low-Molecular-Mass Serum Proteome
Brief report · 30 Sep 2024
Advances in Mass Spectrometry-Based Proteomics for Biomarker Discovery in Cancer Research
Conference abstract · 17 Sep 2018
Applications of lectin-based proteomics in cancer biomarker discovery research
More from this journal
The newest in Journal of Proteomics & Bioinformatics.
Perspective · 30 Dec 2025
Advances in Molecular Docking for Predicting Protein Ligand Interactions
Commentary · 30 Dec 2025
Machine Learning in Bioinformatics Transforming Biological Data into Predictive Insights
Perspective · 30 Dec 2025
Post-Translational Modifications as Dynamic Regulators of Proteome Complexity and Cellular Function
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Proteomics & Bioinformatics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Kian Kani”

